Desferal Injection, Powder, Lyophilized, For Solution
Product Images NDC 0078-0467

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Desferal (NDC 0078-0467). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Novartis Pharmaceuticals Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Desferal 01

Desferal 500 mg per vial injection powder, lyophilized for solution, by Novartis Pharmaceuticals Corporation. The label indicates deferoxamine mesylate USP as the active ingredient. The package contains 4 vials intended for intramuscular, intravenous, or subcutaneous administration. The label includes storage instructions and manufacturer details, with a National Drug Code (NDC) 0078-0467-91.*

FDA Label Image

Chemical Structure (Desferal 02)

Chemical structure of deferoxamine mesylate, showing the molecular arrangement visually depicting its atoms and bonds as per the product's active ingredient.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.